A detailed history of Apis Capital Advisors, LLC transactions in Celcuity Inc. stock. As of the latest transaction made, Apis Capital Advisors, LLC holds 776,000 shares of CELC stock, worth $71.7 Million. This represents 11.85% of its overall portfolio holdings.

Number of Shares
776,000
Holding current value
$71.7 Million
% of portfolio
11.85%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$12.58 - $62.68 $9.76 Million - $48.6 Million
776,000 New
776,000 $38.1 Million

Others Institutions Holding CELC

About Celcuity Inc.


  • Ticker CELC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 14,941,300
  • Market Cap $1.38B
  • Description
  • Celcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therap...
More about CELC
Track This Portfolio

Track Apis Capital Advisors, LLC Portfolio

Follow Apis Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Apis Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Apis Capital Advisors, LLC with notifications on news.